Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 3.690
-0.010 (-0.27%)
Sep 5, 2025, 10:45 AM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Wholesale Medical Customers | 5.96B | Log In | Log In | Log In | Log In | Upgrade |
Wholesale Medical Customers Growth | -3.02% | Log In | Log In | Log In | Log In | Upgrade |
Nutritional Supplements | 3.75B | Log In | Log In | Log In | Log In | Upgrade |
Nutritional Supplements Growth | 30.96% | Log In | Log In | Log In | Log In | Upgrade |
Wholesale Commercial Customers | 2.26B | Log In | Log In | Log In | Log In | Upgrade |
Wholesale Commercial Customers Growth | -9.51% | Log In | Log In | Log In | Log In | Upgrade |
Retail | 1.69B | Log In | Log In | Log In | Log In | Upgrade |
Retail Growth | 5.67% | Log In | Log In | Log In | Log In | Upgrade |
Anti-virus and Anti-infection | 1.00B | Log In | Log In | Log In | Log In | Upgrade |
Anti-virus and Anti-infection Growth | -1.52% | Log In | Log In | Log In | Log In | Upgrade |
Cold Medicine | 395.32M | Log In | Log In | Log In | Log In | Upgrade |
Cold Medicine Growth | -26.30% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular | 329.83M | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Growth | 48.88% | Log In | Log In | Log In | Log In | Upgrade |
Industrial - Other | 316.63M | Log In | Log In | Log In | Log In | Upgrade |
Industrial - Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Anti-tumor | 286.31M | Log In | Log In | Log In | Log In | Upgrade |
Anti-tumor Growth | 33.67% | Log In | Log In | Log In | Log In | Upgrade |
Other | 175.69M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 84.89% | Log In | Log In | Log In | Log In | Upgrade |
Digestive System | - | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
China | 14.72B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 2.29% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 1.46B | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 36.40% | Log In | Log In | Log In | Log In | Upgrade |